Does PANITUMUMAB Cause Hepatic lesion? 38 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 38 reports of Hepatic lesion have been filed in association with PANITUMUMAB (Vectibix). This represents 0.4% of all adverse event reports for PANITUMUMAB.
38
Reports of Hepatic lesion with PANITUMUMAB
0.4%
of all PANITUMUMAB reports
11
Deaths
11
Hospitalizations
How Dangerous Is Hepatic lesion From PANITUMUMAB?
Of the 38 reports, 11 (28.9%) resulted in death, 11 (28.9%) required hospitalization, and 1 (2.6%) were considered life-threatening.
Is Hepatic lesion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PANITUMUMAB. However, 38 reports have been filed with the FAERS database.
What Other Side Effects Does PANITUMUMAB Cause?
Rash (1,392)
Diarrhoea (1,123)
Death (767)
Dermatitis acneiform (758)
Neutropenia (757)
Skin toxicity (728)
Neuropathy peripheral (613)
Hypomagnesaemia (611)
Nausea (608)
Disease progression (600)
What Other Drugs Cause Hepatic lesion?
OCTREOTIDE (296)
EVEROLIMUS (171)
RIBOCICLIB (144)
LETROZOLE (139)
CAPECITABINE (124)
ADALIMUMAB (123)
METHOTREXATE (108)
FULVESTRANT (107)
PALBOCICLIB (104)
CYCLOPHOSPHAMIDE (101)
Which PANITUMUMAB Alternatives Have Lower Hepatic lesion Risk?
PANITUMUMAB vs PANOBINOSTAT
PANITUMUMAB vs PANTOPRAZOLE
PANITUMUMAB vs PANTOPRAZOLE ANHYDROUS
PANITUMUMAB vs PANTOTHENIC ACID
PANITUMUMAB vs PAPAVERINE